A BILL to amend and reenact §§ 2.2-3705.5, 2.2-3711, as it is currently effective and as it shall become effective, and 2.2-4002 of the Code of Virginia and to amend the Code of Virginia by adding a section numbered 32.1-283.9, relating to the Fetal and Infant Mortality Review Team established; penalty; report.
HB336 creates the Fetal and Infant Health Data and Quality Improvement Review Team within the Code of Virginia and gives it authority to review certain fetal and infant deaths through a public health and quality-improvement lens. The team is directed to identify systemic factors, trends, and evidence-based prevention strategies, coordinate with existing child and maternal mortality review bodies to avoid duplication, and develop operating procedures, training recommendations, and policy recommendations aimed at preventing future deaths and supporting affected families. The bill also requires the team to provide aggregate data and triennial statistical reports to the Governor, the General Assembly, and the Department of Health.
The bill also makes related changes to Virginia’s open records, closed meetings, and administrative process laws. It adds the new review team to the list of confidential fatality-review entities in the Virginia Freedom of Information Act and authorizes closed meetings for discussion of individual fetal and infant death cases. It exempts the team’s operating procedures from the Administrative Process Act and establishes confidentiality rules for records, interviews, and deliberations, including destruction of family records after review and misdemeanor penalties for confidentiality violations. The bill also updates closed-meeting language to reflect the new team and adds a reference to complaints about personal use of campaign funds in one closed-meeting provision.
The bill’s impact on state law is primarily to formalize a new statewide review structure focused on fetal and infant mortality and to protect the confidentiality of sensitive medical, family, and investigative information used in that process. It affects the Virginia Freedom of Information Act, closed-meeting rules, and administrative rulemaking exemptions, while also expanding access for the Chief Medical Examiner to certain records after law-enforcement matters conclude. The bill is designed to support data sharing among public health, medical, social services, and law-enforcement stakeholders while limiting public disclosure of case-specific information.
Overall sentiment appears supportive and noncontroversial in the available record. The bill was incorporated by Appropriations, which suggests it moved forward through the legislative process without recorded opposition in the provided materials. No committee transcript or vote breakdown is included, so there is no evidence here of substantive debate or divided votes.
The main points of contention that could arise from the bill are confidentiality and access to records, especially because it authorizes the team to obtain sensitive health, social services, and law-enforcement information and then shields those materials from FOIA, subpoena, discovery, and use in disciplinary or enforcement actions. Another potential issue is the breadth of the team’s authority and membership, including community representatives and advisory panels, though the bill frames these features as necessary to improve prevention and quality improvement efforts.
HB336 amends Virginia’s FOIA exclusions, closed-meeting provisions, and Administrative Process Act exemptions to accommodate a new Fetal and Infant Health Data and Quality Improvement Review Team. It adds § 32.1-283.9, which establishes the team, defines its duties, sets membership and confidentiality requirements, authorizes access to certain records, and requires periodic statistical reporting. It also updates §§ 2.2-3705.5 and 2.2-3711 to make records and meetings related to fetal and infant death reviews confidential, and amends § 2.2-4002 to exempt the team’s operating procedures from APA rulemaking requirements.
The available legislative record suggests generally favorable treatment of the bill. There are no committee transcript excerpts or recorded votes showing opposition, and the bill was incorporated by Appropriations, indicating it advanced as part of the budget-related legislative process. The framing of the measure as a public health and quality-improvement initiative also suggests broad institutional support.
The most likely areas of contention are the bill’s confidentiality provisions and the scope of access to sensitive records. The measure allows the Chief Medical Examiner and the team to review medical, social services, and law-enforcement records after investigations conclude, while also barring disclosure and limiting use of the information in civil, criminal, disciplinary, or regulatory proceedings. Stakeholders concerned with transparency, privacy, or due process could question those restrictions, while supporters are likely to emphasize the need for candid review and protection of families’ information. The bill’s inclusion of a misdemeanor penalty for confidentiality breaches also underscores the seriousness of those concerns.